Open AccessLong-term treatment with proton pump inhibitor is associated with undesired weight gain
Author(s) -
Ichiro Yoshikawa,
Makiko Nagato,
Masahiro Yamasaki,
Keiichiro Kume,
Makoto Ōtsuki
Publication year - 2009
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.15.4794
Subject(s) - lansoprazole , gerd , omeprazole , proton pump inhibitor , medicine , gastroenterology , rabeprazole , body mass index , reflux , weight gain , weight loss , obesity , body weight , disease
To examine the effects of long-term proton pump inhibitor (PPI) therapy on body weight (BW) and body mass index (BMI) in patients with gastroesophageal reflux disease (GERD).